The Journal of Liquid Biopsy (Nov 2023)
Exploring the Role of CK+/CD45+ (Dual-Positive) Circulating Cells in Patients With Early Breast Cancer (EBC)
- E. Nicolo,
- L. Munoz-Arcos,
- M. Serafini,
- L. Gerratana,
- A. Davis,
- H. Liu,
- W. Gradishar,
- G. Curigliano,
- C. Reduzzi,
- M. Cristofanilli
Affiliations
- E. Nicolo
- Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
- L. Munoz-Arcos
- Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA
- M. Serafini
- Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA
- L. Gerratana
- Department of Medical Oncology, Centro di Riferimento Oncologico (CRO) IRCCS, Aviano, Italy
- A. Davis
- Washington University in St. Louis School of Medicine, St. Louis, USA
- H. Liu
- Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, USA
- W. Gradishar
- Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, USA
- G. Curigliano
- Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
- C. Reduzzi
- Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA
- M. Cristofanilli
- Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA
- Journal volume & issue
-
Vol. 1
p. 100046
